0
0
Read Time:5 Minute, 14 Second
NEW DELHI — In a major push to establish traditional systems of medicine alongside modern pharmaceuticals, India’s Ministry of Ayush has outlined a comprehensive multi-tier strategy to enforce rigorous quality control, standardization, and international safety compliance for AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homeopathy) formulations.
The initiative comes at a crucial time. With global demand for plant-based therapies and holistic medicine surging, regulatory bodies are moving to eliminate historical concerns regarding product purity, heavy metal contamination, and batch-to-batch inconsistency. The new framework aims to ensure that when a consumer purchases an AYUSH remedy, whether in New Delhi or New York, it meets standardized benchmarks for safety, identity, and active potency.
Standardizing Ancient Science for Modern Healthcare
For decades, traditional systems of medicine operated under distinct regulatory expectations compared to synthetic drugs. However, under the provisions of the Drugs & Cosmetics Act, 1940, and Drugs Rules, 1945, India has codified strict statutory mandates for AYUSH manufacturing.
Producers must now strictly adhere to Good Manufacturing Practices (GMP)—detailed under Schedule T and Schedule M-I of the Drugs Rules—covering facility hygiene, equipment calibration, raw material verification, and processing controls.
“The fundamental challenge with herbal and traditional remedies has always been consistency,” explains Dr. Ananya Mukherjee, an independent pharmacology researcher based in Mumbai. “Plant profiles vary based on soil, climate, and harvest timing. By enforcing strict pharmacopoeial standards and mandatory GMP, regulatory authorities are ensuring that a botanical extract has a predictable active profile and is free from toxic adulterants.”
Central to this standardization drive is the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). Serving as the primary scientific body under the Ayush Ministry, PCIM&H establishes official monographs, defining identity, purity, and strength limits for raw ingredients and finished formulations.
Multi-Layered Testing and Enforcement Framework
To enforce these quality parameters, statutory Drug Inspectors actively sample products from manufacturing plants and retail shelves across the nation. Samples undergo rigorous testing at designated Drug Testing Laboratories.
Currently, 34 government-operated State and Union Territory laboratories, alongside 118 officially approved private testing facilities, form the backbone of this quality control network. If a sample is declared “Not of Standard Quality” (NSQ), immediate legal mechanisms kick in to pull the batch from the market and penalize the manufacturer.
Furthermore, through the Central Sector Scheme known as AOGUSY (Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana), the ministry provides direct financial and technical assistance to help domestic pharmacies and testing centers achieve accreditation under:
-
WHO-GMP (World Health Organization Good Manufacturing Practices)
-
NABL (National Accreditation Board for Testing and Calibration Laboratories)
AYUSH Quality Verification Architecture
[ Pharmacopoeia Commission (PCIM&H) ]
│
▼ (Sets Monograph Standards)
[ Manufacturing Units (Mandatory GMP Compliance) ]
│
▼ (Routine Market Sampling)
[ 152+ State & Approved Private Testing Labs ]
│
├── Standard Quality ──► Market Distribution / Global Export
└── Substandard (NSQ) ──► Immediate Product Recall & Legal Action
Global Reach and Market Dynamics
These quality benchmarks directly support India’s burgeoning botanical export market. According to official data released by the Directorate General of Commercial Intelligence and Statistics (DGCIS), the United States remains the largest single market for Indian AYUSH and herbal exports, generating $151.56 million in the April 2025 – March 2026 fiscal period, followed by European markets including Germany ($64.31 million) and Italy ($36.08 million).
To facilitate international acceptance, the government has integrated several global certification pathways:
-
WHO Certificate of Pharmaceutical Product (WHO-CoPP): Issued jointly by the Central Drugs Standard Control Organization (CDSCO) and state authorities following physical facility audits.
-
Ayush Quality Mark (AQM): Managed via the Ayush Export Promotion Council (AYUSHEXCIL) to verify statutory approvals for overseas buyers.
-
QCI Certification: The Quality Council of India awards the Ayush Standard Mark and Ayush Premium Mark based on third-party audits against international standards.
-
ISO Harmonization: Inclusion of Ayurveda and Yoga within International Organization for Standardization (ISO) technical committees (ISO/TC249) to standardize international terminology, raw material safety, and finished dietary supplement specifications.
Top International Destinations for Indian AYUSH Products (USD Millions)
| Country | FY 2021-22 | FY 2023-24 | FY 2025-26 |
| United States | $175.43M | $183.49M | $151.57M |
| Germany | $55.04M | $62.71M | $64.32M |
| Italy | $24.60M | $36.26M | $36.08M |
| United Arab Emirates | $26.51M | $25.13M | $32.43M |
| Vietnam | $9.32M | $4.64M | $24.57M |
| France | $19.52M | $16.24M | $24.53M |
Public Health Implications and Patient Safety
For everyday consumers, stronger regulatory oversight offers necessary protections. Herbal products are frequently perceived as naturally safe, but unregulated formulations carry genuine risks—including heavy metal toxicity (such as lead, mercury, or arsenic), herb-drug interactions, and contamination with synthetic pharmaceuticals.
Integrative health experts emphasize that standardization bridges the gap between traditional wisdom and modern consumer safety expectations.
“Patients often assume ‘natural’ automatically means ‘harmless,'” notes Dr. Rajesh K. Sharma, a senior consultant in integrative internal medicine not affiliated with the ministry. “That is a dangerous misconception. Traditional formulations contain complex bio-active compounds. Strict standardization ensures that patients receive precise therapeutic dosages without exposure to harmful contaminants, micro-organisms, or adulterants.”
What This Means for Consumers
-
Look for Certification Marks: When buying AYUSH products, check packaging for official seals like the Ayush Premium Mark or WHO-GMP certification.
-
Disclose Traditional Medicine Use: Always inform your primary care physician about any traditional, herbal, or homeopathic supplements you take, as active botanicals can interact with prescription medications (such as blood thinners or immunosuppressants).
-
Report Adverse Reactions: If you suspect a side effect or adverse reaction from a traditional medicine, notify your healthcare provider and report it through consumer health safety portals.
While regulatory bodies continue to expand laboratory capacity and international MoUs (including 27 country-to-country agreements to date), experts note that consumer education remains critical. Enforcing quality standards protects public health while providing a scientific foundation for traditional healing practices on the world stage.
References
-
Government Document: Press Information Bureau (PIB) Delhi, Ministry of Ayush, Statement on Standardization of AYUSH Medicines, Published Aug 07, 2026.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
